Novavax starts COVID-19 vaccine trials on children
US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.
by ·
US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.
by · Published May 27, 2021
by · Published May 26, 2021
by · Published April 15, 2021